Cat. No. Name Size Price Add Cart
KI0756Sumatriptan succinate25 mg$154

Chemical Characteristic

Product NameSumatriptan succinate
SynonymsImitrex, Imigran ,Treximet, GR 43175
CAS No.103628-48-4
Molecular Weight 413.49
FormulaC18H27N3O6S
Chemical Name1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide succinate
SmilesC(S(=O)(=O)NC)c1cc2c(c[nH]c2cc1)CCN(C)C C(=O)(CCC(=O)O)O
Chemical Structure

Biological activities

Sumatriptan succinate is the succinate salt form of sumatriptan. Sumatriptan is a selective 5-HT1B/1D-receptor agonist. The IC50 value of sumatriptan for 5-HT1B, 5-HT1D and 5-HT1F receptor is 9.3, 7.3 and 17.8 nM, respectively. The Emax value of sumatriptan for 5-HT1D and 5-HT1B receptor is 98% and 101% of the maximal 5-HT (10 µM), respectively. The Emax value of sumatriptan for HMMA is 105% of the KCl (45 mM).[1]Sumatriptan displays moderate affinity for 5-HT1D and 5-HT1A receptors with Ki of 17 and 100 nM, respectively.[2] Sumatriptan is a full agonist at the h5-HT1B receptor with an IC50 of 20 nM in HEK 293 cells and h5-HT1D receptors with an IC50 of 2.6 nM, respectively.[3] Sumatriptan inhibits evoked IPSCs (inhibitory postsynaptic currents) with an IC50 of 261 nM. Sumatriptan (3 µM) also reduces the amplitude of non-NMDA mediated evoked excitatory postsynaptic currents (EPSCs) in all PAG neurons tested. Sumatriptan inhibits GABAergic and glutamatergic synaptic transmission within the PAG via a 5-HT1B/D receptor mediated reduction in the probability of neurotransmitter release from nerve terminals. Sumatriptan inhibits evoked GABAergic synaptic currents via a presynaptic mechanism.[4] In vitro in rat medullary dorsal horn neurons, sumatriptan inhibits the miniature EPSC (mEPSC) rate in a dose dependent fashion, with an EC50 of 250 nM. Sumatriptan (3 µM) inhibits the mEPSC rate by 36%, without altering the mEPSC amplitude.[5] In rat, local intracortical perfusion with sumatriptan via the dialysis probe decreases cortical 5-HT (5-hydroxytryptamine, serotonin) release with an ED50 value of approximately 0.5 µM.[6] In vivo, sumatriptan (24 and 42 mg/kg) is significantly effective in a reliable animal model of cephalalgia in rats, while having no systemic analgesic activity.[7] In sumatriptan-treated anesthetized pigs, jugular venous oxygen saturation decreases dose dependently with a geometric mean ED50 value of 16 µg/kg, concomitantly with increases in carotid vascular resistance.[8] Sumatriptan reveals selectivity for functional 5-HT1B receptors in rat brain and 5-HT1D receptors in calf brain.[1] Sumatriptan inhibits neurogenic inflammation via 5-HT1Dα receptors in guinea pigs and 5-HT1Dβ (5- HT1B) receptors in rats.[9]

Protocols

In vivo: Sumatriptan is dissolved in saline ( 0.9%).[8]

References

[1] Razzaque Z, et al. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol. 1999, 47(1): 75-82.
[2] McCarthy BG, et al. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache. 1989, 29(7): 420-422.
[3] Lesage AS, et al. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Br J Pharmacol. 1998, 123(8): 1655-1665.
[4] Jeong HJ, et al. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain. 2008, 4: 54.
[5] Jennings EA, et al. Effects of sumatriptan on rat medullary dorsal horn neurons. Pain. 2004, 111(1-2): 30-37.
[6] Johnson DE, et al. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. Eur J Pharmacol. 2001, 425(3): 203-210.
[7] Ottani A, et al. Effect of sumatriptan in different models of pain in rats. Eur J Pharmacol. 2004, 497(2): 181-186.
[8] Létienne R, et al. Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action. J Pharmacol Exp Ther. 2003, 307(1): 168-174.
[9] Yu XJ, et al. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Neuropharmacology. 1997, 36(1): 83-91.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.